#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>Background Information for CDKL5-Related Disorders (CDKL5) Deletion/Duplication: Characteristics: Vary widely but may include early onset intractable seizures, severe developmental delay, with females often exhibiting features of Rett syndrome. Incidence: Unknown; more frequent in females than males. Inheritance: X-linked dominant; reported cases are de novo. Penetrance: 100 percent. Cause: Pathogenic CDKL5 gene mutations. Clinical Sensitivity: Unknown. Methodology: Multiplex ligation-dependent probe amplification (MLPA) to detect large CDKL5 coding region deletions/duplications. Analytical Sensitivity and Specificity: 99 percent. Limitations: Rare diagnostic errors can occur due to probe site mutations. Single base pair substitutions, small deletions/duplications, regulatory region mutations, and deep intronic mutations will not be detected. Large deletions/duplications of exon 3 will not be detected. The breakpoints of large deletions/duplications will not be determined.
Counseling and informed consent are recommended for genetic testing. Consent forms are available online at www.aruplab.com.
See Compliance Statement C: www.aruplab.com/CS
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistCPT>
| CPT Code(s): |
81479
|
*ExistCPT>
#ExistCrossReferences>
Cross References: |
Atypical Rett (CDKL5) (CDKL5-Related Disorders (CDKL5) Deletion/Duplication)
, Epileptic Encehpalopathy, Early Infantile 2 (CDKL5-Related Disorders (CDKL5) Deletion/Duplication)
, Infantile Spasms/Atypical Rett (CDKL5-Related Disorders (CDKL5) Deletion/Duplication)
, Rett-Like Syndrome (CDKL5-Related Disorders (CDKL5) Deletion/Duplication)
|
*ExistCrossReferences>
|